In 9 tumor types (ACC, KIRP, LGG, LIHC, LUAD, MESO, PRAD, PAAD and SARC), high expression of YBX1 corresponded to an unfavorable prognosis, while one tumor type (OV) with low expression of YBX1 exhibited a poor prognosis (Fig. 1D). This evidence concerns the gene YBX1 and pancreatic adenocarcinoma.